Studies related to Incontinence and Cannabis

The Effect Of Cannabis On Urge Incontinence In Patients With Multiple Sclerosis: A Multicentre, Randomised Placebo-controlled Trial (CAMS-LUTS)

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 630
Sex Both Genders
Age Range 45-64, 65+
Body Types Overweight, Average
Notes for this study:
Using data from the CAMS trial (large double blind trial) during a secondary analysis, it appeared that usage of cannabis sativa or isolated THC supplements conferring 25mg THC for 15 weeks appears to significantly reduce rates of incontinence in persons with multiple sclerosis, with reported clinical improvements of 18% in placebo being outperformed by 33-38% with cannabis containing groups.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.